Browsing by Author "Richthammer, Patrick (23983315500)"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication The multifaceted phenotypic and genotypic spectrum of type-IV-collagen-related nephropathy—A human genetics department experience(2022) ;Ćomić, Jasmina (57896737200) ;Riedhammer, Korbinian M. (57200625458) ;Günthner, Roman (6507490502) ;Schaaf, Christian W. (59886124500) ;Richthammer, Patrick (23983315500) ;Simmendinger, Hannes (57897933000) ;Kieffer, Donald (57897456500) ;Berutti, Riccardo (24483074500) ;Tasic, Velibor (7003911066) ;Abazi-Emini, Nora (57896737400) ;Nushi-Stavileci, Valbona (57193881397) ;Putnik, Jovana (14008113300) ;Stajic, Nataša (6602606131) ;Lungu, Adrian (35812503300) ;Gross, Oliver (21934239600) ;Renders, Lutz (6602849386) ;Heemann, Uwe (26643385000) ;Braunisch, Matthias C. (57192699344) ;Meitinger, Thomas (57215631099)Hoefele, Julia (57196082805)Disease-causing variants in COL4A3-5 are associated with type-IV-collagen-related nephropathy, a genetically and phenotypically multifaceted disorder comprising Alport syndrome (AS) and thin basement membrane nephropathy (TBMN) and autosomal, X-linked and a proposed digenic inheritance. Initial symptoms of individuals with AS are microscopic hematuria followed by proteinuria leading to kidney failure (90% on dialysis < age 40 years). In contrast, individuals with TBMN, an outdated histology-derived term, present with microscopic hematuria, only some of them develop kidney failure (>50 years of age). An early diagnosis of type-IV-collagen-related nephropathy is essential for optimized therapy and slowing of the disease. Sixty index cases, in whom exome sequencing had been performed and with disease-causing variant(s) in COL4A3-5, were evaluated concerning their clinical tentative diagnosis and their genotype. Of 60 reevaluated individuals with type-IV-collagen-related nephropathy, 72% had AS, 23% TBMN and 5% focal segmental glomerulosclerosis (FSGS) as clinical tentative diagnosis. The FSGS cases had to be re-classified as having type-IV-collagen-related nephropathy. Twelve percent of cases had AS as clinical tentative diagnosis and a monoallelic disease-causing variant in COL4A3/4 but could not be classified as autosomal dominant AS because of limited or conflicting clinical data. This study illustrates the complex clinical and genetic picture of individuals with a type IV-collagen-related nephropathy indicating the need of a refined nomenclature and the more interdisciplinary teamwork of clinicians and geneticists as the key to optimized patient care. Copyright © 2022 Ćomić, Riedhammer, Günthner, Schaaf, Richthammer, Simmendinger, Kieffer, Berutti, Tasic, Abazi-Emini, Nushi-Stavileci, Putnik, Stajic, Lungu, Gross, Renders, Heemann, Braunisch, Meitinger and Hoefele.